The BalancedInvestor Club

Diagnostics Research Industry Analysis

58 companies analyzed • Returns from -524.3% to +400.8%

Company List (59 Results)

View:
Sort:

Industry Performance

(58/58 companies)
2025-07-22 → 2026-07-20
Weighted Avg
+17.7%
Best
+400.8%
Worst
-524.3%
Returns Distribution
Top 5
1. BDSX+400.8%2. ADVB+263.8%3. GH+116.4%4. CDNA+108.1%5. PRE+94.2%
Bottom 5
1. NOTV-524.3%2. NOTVQ-524.3%3. WGSWW-413.6%4. PRPH-177.3%5. MDXH-175.9%

BDSX

+400.8%

Biodesix Inc

ADVB

+263.8%

Advanced Biomed Inc. Common Stock

GH

+116.4%

Guardant Health Inc

CDNA

+108.1%

CareDx Inc

PRE

+94.2%

Prenetics Global Ltd

TWST

+89.2%

Twist Bioscience Corp

VCYT

+89.0%

Veracyte Inc

NEO

+79.7%

NeoGenomics Inc

ISPC

+79.3%

iSpecimen Inc

CHEK

+74.7%

Check Cap Ltd

EXAS

+74.5%

EXACT Sciences Corporation

PSNL

+73.0%

Personalis Inc

BIAF

+71.2%

bioAffinity Technologies, Inc.

NEOG

+69.0%

Neogen Corporation

NTRA

+63.0%

Natera Inc

GRAL

+61.8%

GRAIL, LLC

ILMN

+59.3%

Illumina Inc

BNR

+54.7%

Burning Rock Biotech Ltd

IMDX

+53.3%

Insight Molecular Diagnostics Inc.

PRPO

+52.8%

Precipio Inc

1–20 of 59
Page 1 of 3
Methodology

The Weighted Average return (+17.7%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

53 companies with market cap data included: BDSX, ADVB, GH, CDNA, PRE, TWST, VCYT, NEO, ISPC, CHEK and 43 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer